Stocks making the biggest moves midday: SpaceX, JPMorgan, UniQure, Intel, Figma, Nano Nuclear & more

Midday movers were driven by a mix of earnings beats, analyst actions, product milestones and momentum in high-growth names. La-Z-Boy jumped 19% on 11% retail sales growth and a 9.9% adjusted operating margin, UniQure surged nearly 75% after FDA alignment on its Huntington's gene-therapy filing, and Jabil rose almost 4% on a beat-and-raise quarter. On the downside, CarMax fell 7% despite beating EPS expectations, Salesforce slipped again to its lowest since early 2023, and AT&T dropped 3% after naming a new CFO.

Analysis

The market’s internal message is that capital is rotating from “story” into “proof.” Banks making fresh highs alongside stronger cyclicals like industrial tech and furniture suggests the leadership is broadening into balance-sheet-sensitive names that benefit from both stable funding costs and better loan demand, not just a growth multiple expansion. That matters because when financials and semis rally together, it usually signals the market is pricing a soft-landing regime rather than a narrow AI-only trade.

The more interesting second-order effect is the quality-of-signal reset across software and consumer. Salesforce’s continued slide implies investors are punishing duration and incremental deceleration, while Figma’s strength shows they still pay up for software names where adoption is early and TAM is underpenetrated. That creates a clean dispersion trade: long “new platform” software, short mature enterprise suites with slowing growth and crowded ownership.

In biotech and speculative energy/space, the market is rewarding de-risking events, not just narrative. UniQure and Nano Nuclear are being treated as catalyst stocks where regulatory validation or credible commercialization timelines can re-rate valuation quickly, but that also means upside is increasingly dependent on the next milestone rather than the headline itself. The post-IPO pullback in the rocket name is consistent with supply coming out after the first lockup-like profit-taking window, so near-term weakness there is more about positioning than fundamentals.

The contrarian read is that several winners may be too “clean” in the short term. Banks at highs leave little margin for a rates or credit wobble, and chip names recovering after a broad rotation can fade if investors stop rewarding beta and start demanding earnings durability. Conversely, the sharp selloff in the furniture name may be overdone if household replacement demand is turning and margin leverage is inflecting; the key is whether this is a one-quarter catch-up trade or the start of a more durable demand recovery.

Key Decisions for Investors

• Long FIG / short CRM for 3-6 months: own the early-adoption software story while fading a crowded mature enterprise multiple; target 15-20% relative outperformance if adoption momentum persists.
• Add to JPM/BAC via call spreads on any 1-2 day pullback: banks are breaking out on breadth, but the risk/reward is better through defined-risk upside than outright equity at all-time highs.
• Go long QURE into regulatory follow-through, but size as a catalyst trade only: hold 1-3 months, take profits into any strength above prior resistance because the move likely prices a large fraction of success.
• Fade LION on rallies with a short or put spread over 2-4 weeks: the strategic M&A premium is gone, and the stock likely reverts as deal optionality gets repriced lower.
• Consider a tactical long LZB against short discretionary retail exposure for 1-2 quarters: the stock’s move looks like an earnings quality re-rate, not just a meme squeeze, but keep stops tight if consumer spending data weakens.